Literature DB >> 2201257

Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas.

R R Reves1, M Fong, L K Pickering, A Bartlett, M Alvarez, B E Murray.   

Abstract

In a previous study, we found fecal colonization with multiresistant Escherichia coli exhibiting high-level trimethoprim resistance in 19% of diapered children attending six day-care centers in Houston, Tex. To examine the potential risk factors associated with this finding, we conducted cross-sectional studies among 203 children attending 12 day-care centers, 51 children attending a well-child clinic (controls), and 64 medical students. The prevalence of fecal colonization with trimethoprim-resistant E. coli among children attending day-care centers (30%) was higher (P less than 0.001) than among control children (6%) or medical students (8%). The prevalence of colonization among the children attending the 12 centers ranged from 0 to 59% and was correlated with the number of diapered children enrolled (r = 0.73; P less than 0.01). In a case control study among the day-care center children, significant risk factors were an age of less than 12 months and attendance at a center with an enrollment of over 40 diapered children (odds ratios of 2.2 and 3.5, respectively); ethnicity, duration of attendance, and prior antibiotic administration were not associated with colonization. Plasmid analysis of 60 of the day-care center strains revealed 22 profiles, each of which was unique to a given day-care center. Transmission and carriage of trimethoprim-resistant strains for as long as 6 months was documented in one center studied on three occasions. Given the documented transmission of enteric pathogens among diapered children attending day-care centers and their spread into family members, it is likely that day-care centers are an important community reservoir of plasmid-associated antibiotic-resistant E. coli.

Entities:  

Mesh:

Year:  1990        PMID: 2201257      PMCID: PMC175994          DOI: 10.1128/AAC.34.7.1429

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

Review 1.  Resistance of Shigella, Salmonella, and other selected enteric pathogens to antimicrobial agents.

Authors:  B E Murray
Journal:  Rev Infect Dis       Date:  1986 May-Jun

2.  Five-year survey of changing patterns of susceptibility of bacterial uropathogens to trimethoprim-sulfamethoxazole and other antimicrobial agents.

Authors:  U Alon; G Davidai; M Berant; D Merzbach
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

3.  Epidemic multiresistant Escherichia coli infection in West Lambeth Health District.

Authors:  I Phillips; S Eykyn; A King; W R Gransden; B Rowe; J A Frost; R J Gross
Journal:  Lancet       Date:  1988-05-07       Impact factor: 79.321

4.  Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.

Authors:  C A Kauffman; M K Liepman; A G Bergman; J Mioduszewski
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

Review 5.  Drug resistance in gram-negative aerobic bacilli.

Authors:  B Rowe; E J Threlfall
Journal:  Br Med Bull       Date:  1984-01       Impact factor: 4.291

6.  Trimethoprim resistance amongst urinary pathogens in south India.

Authors:  H K Young; M V Jesudason; G Koshi; S G Amyes
Journal:  J Antimicrob Chemother       Date:  1986-05       Impact factor: 5.790

7.  Rotavirus in infant-toddler day care centers: epidemiology relevant to disease control strategies.

Authors:  A V Bartlett; R R Reves; L K Pickering
Journal:  J Pediatr       Date:  1988-09       Impact factor: 4.406

8.  Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries.

Authors:  B E Murray; T Alvarado; K H Kim; M Vorachit; P Jayanetra; M M Levine; I Prenzel; M Fling; L Elwell; G H McCracken
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

9.  Children with trimethoprim- and ampicillin-resistant fecal Escherichia coli in day care centers.

Authors:  R R Reves; B E Murray; L K Pickering; D Prado; M Maddock; A V Bartlett
Journal:  J Infect Dis       Date:  1987-11       Impact factor: 5.226

10.  Transfer of trimethoprim resistance from fecal Escherichia coli isolated during a prophylaxis study in Mexico.

Authors:  B E Murray; E R Rensimer
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

View more
  18 in total

1.  Contagious diseases of child day care.

Authors:  L K Pickering; A L Morrow
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

2.  Comparative in vitro activities of amoxicillin-clavulanic acid, cefuroxime, cephalexin, and cephalothin against trimethoprim-resistant Escherichia coli isolated from stools of children attending day-care centers.

Authors:  K V Singh; R R Reves; L K Pickering; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Antimicrobial resistance of fecal aerobic gram-negative bacilli in different age groups in a community.

Authors:  T Leistevuo; J Leistevuo; M Osterblad; T Arvola; P Toivonen; T Klaukka; A Lehtonen; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 4.  A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131.

Authors:  Ritu Banerjee; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

5.  Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children.

Authors:  U D Allen; N MacDonald; L Fuite; F Chan; D Stephens
Journal:  CMAJ       Date:  1999-05-18       Impact factor: 8.262

6.  Problem of antimicrobial resistance of fecal aerobic gram-negative bacilli in the elderly.

Authors:  T Leistevuo; P Toivonen; M Osterblad; M Kuistila; A Kahra; A Lehtonen; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

Review 7.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

8.  The prevalence of antimicrobial resistance in human faecal flora in South Africa.

Authors:  P M Shanahan; B A Wylie; P V Adrian; H J Koornhof; C J Thomson; S G Amyes
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

9.  Impact of outpatient antibiotic use on carriage of ampicillin-resistant Escherichia coli.

Authors:  Matthew H Samore; Claude Tonnerre; Elizabeth Lyon Hannah; Gregory J Stoddard; Robert J Borotkanics; Bassam Haddadin; Stephan Harbarth
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

10.  Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children.

Authors:  Xuan Qin; Yasmin Razia; James R Johnson; Jennifer R Stapp; Daniel R Boster; Treva Tsosie; Donna L Smith; Christopher R Braden; Kathryn Gay; Frederick J Angulo; Phillip I Tarr
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.